首页> 美国卫生研究院文献>Molecules >A Drug Content Stability Analysis and Qualitative Assessment of Pharmacists’ Opinions of Two Exemplar Extemporaneous Formulations
【2h】

A Drug Content Stability Analysis and Qualitative Assessment of Pharmacists’ Opinions of Two Exemplar Extemporaneous Formulations

机译:药剂师对两种示例性局部配方的药剂师观点的药物含量稳定性分析和定性评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Despite a decline in the number of active pharmaceutical ingredients prepared extemporaneously using proprietary products, there remains a need for such products in the community (for example, liquid medicines for paediatrics which may be otherwise commercially unavailable). A lack of experience and quality assurance systems may have diminished pharmacist’s confidence in the extemporaneous preparation process; therefore, pharmacists were asked to prepare two proprietary products, omeprazole and amlodipine. The resulting products were characterised in terms of variability in drug quantity, stability, particle size and antimicrobial properties. Furthermore, a self-administered questionnaire was used to assess 10 pharmacists’ opinions on the perceived complexity of the extemporaneous compounding process and their overall confidence in the final extemporaneously compounded products. Drug content studies revealed that 88.5% and 98.0% of the desired drug content was obtained for omeprazole and amlodipine, respectively. Antimicrobial properties were maintained for both drugs, however variability in particle size, particularly for amlodipine, was evident between formulations. While pharmacists who partook in the study had some or high confidence in the final products, they reported difficulty formulating the suspensions. Findings from this study provide insight into pharmacists’ views on two extemporaneously prepared products and highlight the variability obtained in preparations prepared by different pharmacists.
机译:尽管使用专有产品中营养的活性药物成分的数量下降,但仍然需要在社区中进行这种产品(例如,用于儿科的液体药物,其可以在商业上不可用)。缺乏经验和质量保证系统可能会减少药剂师对即时制备过程的信心;因此,药剂师被要求准备两种专有产品,奥美拉唑和氨氯蝶。所得产物的特征在于药物量,稳定性,粒度和抗微生物性能的可变性。此外,使用自我管理的问卷来评估10名药剂师对省光过程中省量复杂性的复杂性及其对最终的最终复合产品的总体信心的意见。药物含量研究表明,对于奥美拉唑和氨氯唑,分别获得88.5%和98.0%所需的药物含量。为两种药物维持抗菌性质,但是在制剂之间明显明显是粒度的可变性,特别是氨氯地平。虽然Partook在该研究中的药剂师对最终产品有一些或高信任,但他们报告难以制定悬浮液。本研究的调查结果提供了对药剂师对两种即兴制造的产品的看法,并突出了不同药剂师制备的制剂中获得的可变性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号